|
|
||||
|
|
||||
|
||||
Tumor Biology |
The Ohio State University, Columbus, OH 43210 (T.C.C., D.K.P., S.D.J., A.J.Y.); Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan (T.T.); Mayo Foundation, Rochester, MN 55905 (D.K., B.W.S.); and Johns Hopkins University, Baltimore, MD 21287 (P.C.B.)
2 Address correspondence and reprint requests to Allan J. Yates, M.D., Ph.D., Professor and Head, Division of Neuropathology, Room 4168 Graves Hall, 333 West 10th Ave., Columbus, OH 43210.
Abstract
Immunohistochemical staining intensity for ganglioside GD1b was determined for 108 human neuroectodermal tumors. Most of the tissue elements that immunostained were tumor cells; only a few axons and occasional neurons reacted in some specimens. All pilocytic astrocytomas stained very positively, whereas none of the ependymomas and only 11% of primitive neuroectodermal tumors, 20% of glioblastomas, and 28% of anaplastic astrocytomas showed more than faint staining. A similar association between grade and immunostaining was seen in tumors containing an oligodendrogliomatous component, but reactivity was not as strong as in astrocytic tumors or primitive neuroectodermal tumors. Results of Cox regression showed significant associations between immunostaining intensity and survival for all cases taken together (P = 0.007); for the group consisting of astrocytomas, oligoastrocytomas, and oligodendrogliomas (P = 0.002); and for astrocytomas alone (P = 0.04). Results were also significant using a proportional hazards model controlling for patient age (all cases P = 0.005; astrocytomas only P = 0.02), but not when controlling for tumor grade. Our results indicate that immunohistochemical staining for GD1b is correlated with tumor grade and that it may be of prognostic utility in some primary human brain tumors, especially astrocytomas.
References
Berra, B., Gaini, S.M., and Riboni, L. (1985) Correlation between ganglioside distribution and histological grading of human astrocytomas. Int. J. Cancer 36,363 -366.[Medline]
Chester, M.A. (1998) IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids. Recommendations 1997. Eur. J. Biochem. 257,293 -298.[Web of Science][Medline]
Daumas-Duport, C. (1992) Histological grading of gliomas. Current Opin. Neurol. Neurosurg. 5, 924-931.
Daumas-Duport, C., Scheithauer, B., O'Fallon, J., and Kelly, P. (1988) Grading of astrocytomas: A simple and reproducible method. Cancer 62,2152 -2165.[CrossRef][Web of Science][Medline]
El-Abbadi, M., and Seyfried, T.N. (1994) In`uence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol. Chem. Neuropathol. 21,273 -285.[Medline]
Finlay, J.L., Boyett, J.M., Yates, A.J., Wisoff, J.H., Milstein,
J.M., Geyer, J.R., Bertolone, S.J., McGuire, P., Cherlow, J.M., Tefft, M.,
Turski, P.A., Wara, W.M., Edwards, M., Sutton, L.N., Berger, M.S., Epstein,
F., Ayers, G., Allen, J.C., Packer, R.J. (1995) Randomized phase
III trial in childhood high-grade astrocytoma comparing vincristine,
lomustine, and prednisone with the eight-drugs-in-1-day regimen. J.
Clin. Oncol. 13,112
-123.
Fredman, P., von Holst, H., Collins, V.P., Granholm, L., and Svennerholm, L. (1988) Siallyllactotetraosylceramide, a ganglioside marker for human malignant gliomas. J. Neurochem. 50,912 -919.[CrossRef][Web of Science][Medline]
Jennemann, R., Rodden, A., Bauer, B.L., Mennel, H.D., and Wiegandt,
H. (1990) Glycosphingolipids of human gliomas. Cancer
Res. 50,7444
-7449.
Kernohan, J.W., Mabon, R.F., Svien, H.J., Adson, A.W. (1949) A simplified classification of the gliomas. Mayo Clinic Proc. 24,71 -74.[Medline]
Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993) Histological Typing of Tumours of the Central Nervous System. International Histological Classi-fication of Tumours, World Health Organization. Second edition. New York: Springer-Verlag.
Kostic, D., and Bucheit, F. (1970) Gangliosides in human brain tumors. Life Sci. (Pt. 2) 9, 589-596.[CrossRef]
Ledeen, R.W., and Yu, R.K. (1982) Gangliosides: Structure, isolation, and analysis. Methods Enzymol. 83,139 -191.[Web of Science][Medline]
Ledeen, R.W., Yu, R.K., and Eng, L.F. (1973) Gangliosides of human myelin: Sialosylgalactosylceramide (G7) as a major component. J. Neurochem. 21,829 -839.[CrossRef][Web of Science][Medline]
Ozawa, H., Kotani, M., Kawashima, I., and Tai, T. (1992) Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Biochim. Biophys. Acta 1123,184 -190.[Medline]
Ringertz, N. (1949) Grading of gliomas. Acta Pathol. Microbiol. Scand. 27, 51-64.
Ross, G.W., and Rubinstein, L.J. (1989) Lack of histopathological correlation of malignant ependymomas with postoperative survival. J. Neurosurg. 70, 31-36.[Medline]
Segler-Stahl, K., Webster, J.C., and Brunngraber, E.G. (1983) Changes in the concentration and composition of human brain gangliosides with aging. Gerontology 29,161 -168.[Medline]
Seyfried, T.N., El-Abbadi, M., Ecsedy, J.A., Bai, H.W., and Yohe, H.C. (1996) In`uence of host cell infiltration on the glycolipid content of mouse brain tumors. J. Neurochem. 66,2026 -2033.[Medline]
Sung, C.C., Pearl, D.K., and Yates, A.J. (1993) Ganglioside composition of human brain tumors. J. Neurochem. 61,S232 .
Sung, C.C., Pearl, D.K., Coons, S.W., Scheithauer, B.W., Johnson, P.C., and Yates, A.J. (1994) Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. Cancer 74,3010 -3022.[CrossRef][Medline]
Svennerholm, L. (1980) Ganglioside designation. Adv. Exp. Med. Biol. 125, 11.[Medline]
Traylor, T.D., and Hogan, E.L. (1980) Gangliosides of human cerebral astrocytomas. J. Neurochem. 34,126 -131.[CrossRef][Web of Science][Medline]
Vanier, M.T., Holm, M., Ohman, R., and Svennerholm, L. (1971) Developmental profiles of gangliosides in human and rat brain. J. Neurochem. 18,581 -592.[Web of Science][Medline]
Wiegandt, H. (1982) The gangliosides. In Agranoff, B.W., and Aprison, M.H. (Eds.), Advances in Neurochemistry, Vol. 4. New York: Plenum Press. pp. 149-223.
This article has been cited by other articles:
![]() |
S. Hettmer, C. Malott, W. Woods, S. Ladisch, and K. Kaucic Biological Stratification of Human Neuroblastoma by Complex "B" Pathway Ganglioside Expression Cancer Res., November 1, 2003; 63(21): 7270 - 7276. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|